Clinical Trials · NCT06913023
Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus
- Phase
- Phase 2/Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- University Health Network, Toronto
- Enrollment
- 37
- Start date
- Sep 2026
- Locations
- 2 sites, Canada
- Primary endpoint
- 2-hour OGTT